Understanding TGA access pathways for unlicensed medicines in Australia
Covering the Special Access Scheme, Authorised Prescriber pathway, Section 19A, Managed Access Programs, clinical trial supply and post-trial access, with information on selecting a pathway and managing the supply chain.
This guide is intended for health professionals, sponsors, CROs and healthcare organisations. Please share a few details below to access your copy.
Your details will be handled in accordance with our privacy policy and will not be used for marketing without your consent.